Sven-Erik Lennart Nilsson

ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark.

HemoCue AB develops, produces, and markets medical diagnostic products for point of care testing. Its solutions include hematology, diabetes, data management and connectivity solutions, and accessories and consumables. The company was founded in 1982 and is heaquartered in Angelholm, Sweden.

Protista International AB develops and manufactures pharmaceutical products. It focuses on research in the area of biotechnology with a focus on fermentation and bioseparation. The company was founded in 2001 and is headquartered in Bjuv, Sweden.

Remedium Oy is a clinical research organisation providing clinical research services to pharmaceutical, food and biotech companies. Remedium areas of expertise are cardiology and cardiovascular diseases, oncology, immunology and vaccines, CNS, endocrinology and medical devices. The company is headquartered in Espoo, Finland

Tigran Technologies AB engaged in the sales and development of dental supplies and technology. Its products included titanium granules and PeriBrush. The company was founded in August 2000 by Lars Bruce and Ingrid Bruce and was headquartered in Malmö, Sweden.